['atopic dermatitis']
['am1030-cream or placebo']

        Inclusion Criteria:

          -  Males and/or females of any ethnic origin between 18 and 65 years of age

          -  Body mass index between 18.0 and 35.0 kg/m2

          -  Subjects with AD as defined by the Hanifen and Rajka criteria and with mild to severe
             disease activity (IGA 2-4)

          -  AD lesions amenable to cutaneous treatment located on the trunk and/or limbs

        Exclusion Criteria:

          -  Subjects with scars, moles, tattoos, sunburn or other blemishes in test areas

          -  Systemic treatment with immunosuppressants, immunomodulators or corticosteroids within
             2 weeks prior to dosing

          -  Topical treatment with corticosteroids, antibiotics and/or immunomodulators within 4
             days prior to dosing

          -  Treatment with systemic antihistamines within 24 hours of the first dose
             administration

          -  Treatment with SSRIs within 2 weeks of the first dose administration

          -  Subjects who have received phototherapy within 4 weeks prior to dosing
      